Merged from 2 sources — review for redundancy.
Salmonella is a genus of gram-negative, facultative anaerobic bacteria that causes salmonellosis, one of the most common food-borne infections worldwide. Over 2,500 serotypes exist, with S. enterica (serovars Typhimurium and Enteritidis) and S. typhi being most clinically relevant. Evolutionarily, Salmonella has exerted selective pressure on human immune system genetics, particularly influencing ABO blood groups polymorphisms and innate immunity response patterns. The bacterium's survival strategy—invading epithelial cells and persisting within macrophages—represents a sophisticated host-pathogen arms race spanning millions of years.
Imagine Salmonella as a sophisticated burglar with two master keys and a secret hideout. The first key is its Type III Secretion System (T3SS)—think of it as a molecular syringe that injects "door-opening proteins" into the intestinal wall, forcing cells to open up and let the bacteria in. Once inside the intestinal cell, Salmonella doesn't just ransack the place—it triggers the alarm system (inflammation) but in a calculated way that creates chaos beneficial to the burglar.
Here's where it gets clever: the inflammation it triggers is like setting off sprinklers in a building. The immune system floods the area with neutrophils (fire brigade) and produces oxidative byproducts including tetrathionate—a sulfur compound that most gut bacteria can't use. But Salmonella has a second key: tetrathionate respiration machinery. While beneficial bacteria like Lactobacillus and Bifidobacteria are drowning in the inflammatory flood, Salmonella uses tetrathionate as fuel, thriving in the chaos it created. It's like a fire-starter who brought scuba gear.
The secret hideout? Salmonella survives inside macrophages—the very immune cells sent to destroy it. It's like a burglar hiding in the police car, allowing systemic spread to liver, spleen, and bone marrow. Blood group O individuals have an advantage here—their immune "police force" recognizes and neutralizes Salmonella more effectively, likely due to antibody patterns that evolved under selective pressure from repeated pathogen exposure over human evolution.
Salmonella pathogenesis involves multiple overlapping phases with precise molecular choreography:
- Adhesion: Salmonella crosses the mucus layer using flagellar motility and fimbrial adhesins, binding to M cells in Peyer's patches or directly to enterocytes
- Type III Secretion System-1 (T3SS-1) activation: Upon contact with epithelial cells, Salmonella injects effector proteins (SopE, SopE2, SopB) into host cytoplasm
- Membrane ruffling: Effectors activate Rho GTPases (Cdc42, Rac1) → actin cytoskeleton rearrangement → formation of membrane ruffles that engulf bacteria
- Internalization: Bacteria enter Salmonella-containing vacuole (SCV)
graph TD
A[Salmonella in SCV] --> B[T3SS-2 activation]
B --> C[SPI-2 effector injection]
C --> D[SifA prevents lysosome fusion]
C --> E[SseF/SseG form tubular network]
C --> F[SopB maintains acidic pH]
D --> G[Bacterial replication in SCV]
E --> G
F --> G
G --> H[Macrophage survival]
H --> I[Systemic dissemination]
H --> J[Chronic carrier state]
- T3SS-2 expression: Inside SCV, bacteria sense environmental cues (low pH, low Mg²⁺) → activate SPI-2 (Salmonella Pathogenicity Island-2) genes
- Lysosomal evasion: SifA effector prevents fusion of lysosomes with SCV; SopB maintains optimal pH 4.5-5.0 for bacterial metabolism
- Nutrient acquisition: SseF/SseG create tubular extensions from SCV to access host nutrients; bacteria also express iron acquisition systems (siderophores) to sequester iron from host ferritin
-
PAMPs recognition:
- LPS (lipid A moiety) → TLR4 → MyD88 → NF-kB activation
- Flagellin → TLR5 → NF-kB and inflammasome activation
- T3SS components → NLRP3 inflammasome → caspase-1 → IL-1β and IL-18 release
-
Pro-inflammatory cascade:
- NF-kB → transcription of TNF-α, IL-6, IL-8, IL-12
- IL-8 (CXCL8) → neutrophil chemotaxis and epithelial barrier disruption
- TNF-α + IFN-γ → increased vascular permeability and fluid secretion (diarrhea)
-
Tetrathionate respiration advantage:
- Neutrophil MPO + H₂O₂ + halides → hypochlorous acid (HOCl)
- HOCl + thiosulfate (from microbial H₂S) → tetrathionate (S₄O₆²⁻)
- Salmonella ttr operon encodes tetrathionate reductase → uses S₄O₆²⁻ as electron acceptor
- This gives Salmonella 10-100x growth advantage over obligate anaerobes during inflammation
¶ Phase 4: Adaptive Immunity and Blood Group O Protection
- T cell response:
- DC uptake of Salmonella → MHC class II presentation
- CD4⁺ T cells differentiate to Th1 phenotype
- IFN-γ production → macrophage activation and iNOS expression
- TNF-α + IFN-γ synergy → enhanced bactericidal activity
- Blood group O protective mechanism:
- Blood group O individuals lack A/B antigens on epithelial cells
- Salmonella adhesins preferentially bind A/B carbohydrates
- O-type secretors have anti-A and anti-B antibodies (IgG, IgA) that cross-react with bacterial polysaccharides
- Result: 30-50% reduced risk of severe salmonellosis in O-type individuals
Salmonella infection is particularly significant in cPNI for several patient populations:
-
Immunocompromised patients (HIV, organ transplant recipients, chemotherapy patients): Risk of systemic infection (bacteremia, osteomyelitis, meningitis) due to impaired Th1 responses and macrophage dysfunction. CD4+ T cells below 200/μL markedly increase risk.
-
Inflammatory bowel disease patients: Pre-existing gut dysbiosis and barrier dysfunction create susceptibility; acute Salmonella infection can trigger IBD flares or unmask latent IBD. Post-infectious IBS occurs in 10-15% of cases.
-
Reactive arthritis/HLA-B27 carriers: 2-3% of Salmonella infections lead to chronic reactive arthritis, particularly in HLA-B27 positive individuals (20-30% of this subset). This represents autoimmunity via molecular mimicry between bacterial and host proteins.
¶ Evolutionary Medicine and Metamodel Context
Evolutionary medicine perspective: Salmonella represents a classic example of antagonistic pleiotropy in host-pathogen coevolution. The ABO blood groups polymorphism has been maintained in human populations partly because each blood type offers differential resistance to various pathogens:
- Type O: protection against Salmonella and severe malaria
- Type A: possible protection against cholera
- Type B: may resist certain E. coli strains
This is an evolutionary trade-off—no single blood type is universally optimal, maintaining genetic diversity.
Mismatch paradigm: Modern food production and global supply chains create evolutionary novel exposure patterns. Humans evolved with sporadic, local Salmonella exposure; now face year-round, high-dose, novel serotype challenges through industrialized animal farming. PPI use (a modern pharmaceutical intervention) increases infection risk 2-4x by eliminating gastric acid barrier—pH >4.0 allows 10⁴-fold more bacteria to survive stomach passage.
5 plus 2 metamodel integration:
- Internal Milieu disturbance: Infection triggers acute phase response, fever (prostaglandin-mediated hypothalamic set-point elevation to 38.5-40°C), negative nitrogen balance
- Microbiome disruption: Creates dysbiotic "post-infectious dysbiosis" lasting 6-12 months; reduced Firmicutes:Proteobacteria ratio
- Immune system activation: Shift from tolerogenic to pro-inflammatory state; Treg suppression during acute phase
- Neuroendocrine response: HPA axis activation with cortisol peak (preventing excessive inflammation but potentially enabling chronic carriage in 2-5% of cases)
¶ Clinical Interventions and Considerations
Biomarkers:
- Calprotectin elevation (>200 μg/g in stool) indicates active neutrophil infiltration
- CRP typically 50-150 mg/L during acute infection
- Procalcitonin >0.5 ng/mL suggests invasive disease requiring antibiotic consideration
Treatment strategy (cPNI perspective):
-
Avoid antibiotics in uncomplicated gastroenteritis: Prolongs fecal shedding (carrier state), disrupts microbiome recovery, increases antibiotic resistance. Reserve for systemic infection, immunocompromised patients, or severe disease.
-
Microbiome restoration: Post-acute phase (after 7-10 days):
-
Immune system support:
- Zinc 30-50 mg/day: cofactor for thymulin synthesis, enhances T cell function
- Vitamin D (if deficient, <30 ng/mL): upregulates cathelicidin and defensins
- Quercetin 500-1000 mg/day: inhibits NLRP3 inflammasome, reduces excessive inflammation
-
Barrier restoration:
-
Reactive arthritis prevention: Early identification of HLA-B27 carriers; aggressive anti-inflammatory approach using curcumin, omega-3 fatty acids, physical therapy if joint symptoms emerge.
- Gram-negative bacillus with >2,500 serotypes; S. enterica Typhimurium and Enteritidis cause 80% of human cases
- Infectious dose: 10³-10⁶ organisms (varies with serotype and host factors); pH <4.5 kills most bacteria (PPI use increases risk)
- Incubation period: 6-72 hours (median 12-36 hours) from ingestion to symptom onset
- Classic presentation: fever 38.5-40°C, non-bloody diarrhea (5-10 stools/day), abdominal cramping, nausea; symptoms last 4-7 days in immunocompetent hosts
- Blood group O individuals have 30-50% reduced risk of severe infection compared to A/B types
- Chronic carrier state develops in 2-5% of adults, up to 25% in gallstone patients (bacteria persist in gallbladder biofilms)
- Post-infectious complications: reactive arthritis (2-3%, higher in HLA-B27⁺), IBS (10-15%), chronic fatigue (5-10%)
- Tetrathionate respiration gives Salmonella 10-100x growth advantage during inflammation—this is why "suppressing inflammation" during acute infection may be counterproductive (removes selective pressure on pathogen)
- Antibiotic use in uncomplicated cases prolongs fecal shedding from 4-5 weeks to 8-12 weeks
- Common sources: poultry (30%), eggs (25%), produce contaminated by animal waste (20%); reptiles and amphibians as pets contribute 5-10% of pediatric cases
- ABO blood groups — blood group O provides 30-50% protection against severe Salmonella infection through altered adhesion and cross-reactive antibodies; example of pathogen-driven balancing selection
- Evolutionary medicine — Salmonella as selective pressure shaping human genetic diversity, particularly in immune-related polymorphisms and blood group maintenance
- Innate immunity — first-line response via TLR4/TLR5 recognition, neutrophil recruitment, and antimicrobial peptide production
- Microbiome — gut microbiome provides colonization resistance; Salmonella exploits inflammation to create dysbiotic niche favorable for its growth
- PAMPs — Salmonella LPS (endotoxin) and flagellin are prototypical PAMPs recognized by pattern recognition receptors
- TLR4 — recognizes Salmonella LPS lipid-A moiety, triggering MyD88-dependent NF-κB activation and cytokine storm
- TLR5 — detects bacterial flagellin, activating both NF-κB pathway and NLRP3 inflammasome
- NLRP3 inflammasome — activated by Salmonella T3SS needle structure and intracellular signals, leading to caspase-1 activation and IL-1β/IL-18 maturation
- Neutrophil — primary effector cell in acute response; produces reactive oxygen species that generate tetrathionate, inadvertently benefiting Salmonella
- Macrophages — Salmonella survives intracellularly in macrophage phagosomes, enabling systemic dissemination and chronic carrier state
- IL-8 — major neutrophil chemoattractant produced by infected epithelium; levels >500 pg/mL correlate with diarrhea severity
- TNF-α — drives fever, endothelial activation, and fluid secretion during acute infection; excessive production can lead to septic shock in severe cases
- IFN-γ — critical for Th1 response and macrophage activation; IFN-γ knockout mice show 100-1000x increased susceptibility to Salmonella
- NF-kB — master transcription factor activated by TLR4/TLR5 signaling; drives pro-inflammatory cytokine gene expression
- Inflammatory bowel disease — pre-existing IBD increases Salmonella susceptibility; conversely, Salmonella can trigger IBD onset or flares through persistent immune activation
- IBS — develops in 10-15% post-Salmonella infection (post-infectious IBS); likely due to persistent low-grade inflammation and altered gut-brain signaling
- HLA-B27 — genetic marker increasing reactive arthritis risk 20-30x after Salmonella infection; example of molecular mimicry and autoimmunity
- Reactive arthritis — post-infectious complication affecting knees, ankles, sacroiliac joints; occurs 2-6 weeks after infection in genetically susceptible individuals
- PPI — proton pump inhibitors increase Salmonella infection risk 2-4x by raising gastric pH >4.0, allowing more bacteria to survive stomach passage
- Lactobacillus — provides colonization resistance through bacteriocin production, lactic acid secretion (lowering luminal pH), and competitive nutrient exclusion
- Bifidobacteria — produces acetate and lactate that create unfavorable environment for Salmonella; populations decimated during acute infection
- Akkermansia-muciniphila — rebuilds mucus layer post-infection; reduced 10-100x during acute phase, slow recovery correlates with post-infectious IBS
- Tetrathionate — sulfur compound produced during inflammation that Salmonella uses as electron acceptor; key to pathogen's bloom during colitis
- Gut dysbiosis — Salmonella infection causes profound dysbiosis with Proteobacteria expansion lasting 6-12 months; associated with metabolic and immune sequelae
- Short-chain fatty acids — protective against Salmonella through multiple mechanisms (tight junction strengthening, Treg induction, pH lowering); butyrate production suppressed during infection
- Intestinal permeability — increased during acute infection via IL-8-mediated tight junction disruption; may persist for months contributing to food sensitivities
- sIgA — secretory IgA provides mucosal defense by preventing bacterial adhesion; levels correlate inversely with infection severity
- Calprotectin — neutrophil-derived protein chelating zinc/manganese; elevated >200 μg/g during acute Salmonella infection, useful for monitoring resolution
- Zinc — essential for immune function; Salmonella infection induces zinc sequestration (nutritional immunity); supplementation may reduce duration and severity
- Iron — Salmonella requires iron for growth; host sequesters iron via hepcidin during infection (causing transient anemia); iron supplementation during acute phase may worsen infection
- Type 1 diabetes — some Salmonella strains exhibit molecular mimicry with pancreatic beta-cell antigens; potential trigger for autoimmune diabetes in susceptible individuals
- Chronic stress — impairs Th1 response through glucocorticoid-mediated immunosuppression; chronic stress increases Salmonella infection risk and severity
This concept appears in:
- Module 1 (Organs I): Context of food-borne pathogens, evolutionary pressure on human genetics, and gut-immune interactions
- Module 7: Broader infectious disease and evolutionary medicine framework
Salmonella is a genus of motile, gram-negative, facultative anaerobic bacteria that primarily causes acute gastroenteritis and, in specific serotypes (e.g., S. typhi), systemic typhoid fever. In cPNI and Evolutionary medicine contexts, Salmonella represents a pathogen that has exerted significant evolutionary selection pressure on human genetics (particularly Blood group O frequency) and epitomizes the critical importance of Nutritional immunity, Gut barrier integrity, and Stomach acid defense mechanisms in preventing invasive infectious disease.
Imagine your gut as a gated community with multiple layers of security. First, there's the acidic moat (stomach acid) that melts most intruders on contact—Salmonella is like a burglar in an acid-resistant wetsuit who can paddle across if the moat is too shallow (e.g., PPI users). Once inside the neighborhood, Salmonella targets the guard stations (M cells in Peyer's patches) by essentially knocking on the door with molecular "access codes" (type III secretion system proteins) that trick the guards into letting it inside. Once in, it doesn't just steal—it hijacks the entire security office (macrophages), hiding inside and manipulating the alarm system so it can't be properly neutralized. Meanwhile, it competes with residents for essential resources like iron, deploying sophisticated "grappling hooks" (Siderophores) to steal iron from the body's locked safes (Transferrins, Ferritin). The body responds by flooding the streets with inflammatory alarms (IL-8, TNF-α), causing chaos (diarrhea) that's meant to flush out the invaders. People with blood type O have slightly reinforced walls that make invasion harder—this is why O blood types became more common in regions with endemic Salmonella and similar pathogens. The gallbladder can become a "safe house" where Salmonella hides long-term, creating chronic carriers (like Typhoid Mary) who unknowingly spread the pathogen for years.
¶ Invasion and Immune Evasion
Initial Breach:
- Salmonella survives gastric acid (pH 1.5-3.5) via acid tolerance response (ATR) systems and urease production → localizes to terminal ileum and cecum
- Uses flagellar motility to penetrate mucus layer → binds to M cells (microfold cells) overlying Peyer's patches in GALT
- Type III secretion system (T3SS) injects effector proteins (SopE, SopB, SipA) → triggers localized actin rearrangement in M cells → "membrane ruffling" → bacterial uptake via macropinocytosis
- Also invades enterocytes directly via T3SS-mediated cytoskeletal manipulation
Intracellular Survival:
- Salmonella-containing vacuole (SCV) formed inside macrophages → bacterial proteins (SifA, SseF, SseG) prevent fusion with lysosomes
- Manipulates phagosome maturation: blocks NADPH oxidase assembly → reduces reactive oxygen species (ROS) production
- Acquires nutrients within macrophage via SCV membrane proteins that import host amino acids and ions
- Survives inside vacuole by expressing stress response genes (rpoS, PhoPQ two-component system)
Iron Competition (Nutritional Immunity):
- Host sequesters iron via:
- Hepcidin upregulation → blocks ferroportin → traps iron in macrophages and hepatocytes
- Lactoferrin in gut lumen binds free iron (Kd ~10⁻²⁰ M)
- Transferrins in serum (normally 20-30% saturated) withhold iron from circulation
- Salmonella counterattacks:
- Produces enterobactin (high-affinity siderophore, Kd ~10⁻⁵² M) → scavenges iron from lactoferrin
- Expresses salmochelin (glycosylated enterobactin) → resistant to lipocalin-2 (NGAL), a host anti-siderophore protein
- Utilizes heme iron via heme oxygenase system when siderophore pathways blocked
Inflammatory Cascade:
- Bacterial LPS (lipid A component) recognized by TLR4 on macrophages, dendritic cells, enterocytes
- TLR4 activation → MyD88 pathway → NF-kB nuclear translocation → transcription of pro-inflammatory cytokines
- IL-8 (CXCL8) release → neutrophil chemotaxis into lamina propria and gut lumen
- TNF-α production → increases vascular permeability, epithelial tight junction disruption (Zonulin upregulation)
- IL-1β release via NLRP3 inflammasome activation (bacterial flagellin and T3SS components trigger assembly)
- Prostaglandin E2 (PGE2) and IL-6 contribute to fever response via hypothalamic signaling
Respiratory Burst Alternative:
- During inflammation, neutrophils and macrophages produce sulfur-containing oxidants (thiosulfate, tetrathionate)
- Salmonella uses tetrathionate as terminal electron acceptor for anaerobic respiration → massive growth advantage over commensal anaerobes
- Also utilizes nitrate (produced from nitric oxide during inflammation) → nitrate respiration via NarGHI reductase
- This creates a "bloom" effect where inflammation feeds pathogen expansion
graph TD
A[Salmonella ingestion] --> B[Survives stomach acid pH 1.5-3.5]
B --> C[Penetrates mucus layer]
C --> D[Binds M cells in Peyer's patches]
D --> E[T3SS injects SopE/SopB/SipA]
E --> F["Membrane ruffling → macropinocytosis"]
F --> G[Inside macrophage in SCV]
G --> H[Blocks phagosome-lysosome fusion]
H --> I[Survives intracellularly]
G --> J[Host immune response]
J --> K[TLR4 recognizes LPS]
K --> L["NF-κB activation"]
L --> M[IL-8 secretion]
L --> N["TNF-α secretion"]
L --> O["IL-1β via NLRP3"]
M --> P[Neutrophil recruitment]
N --> Q[Tight junction disruption]
O --> R[Fever response]
P --> S[ROS and tetrathionate production]
S --> T[Salmonella uses tetrathionate for respiration]
T --> U[Pathogen bloom advantage]
J --> V[Nutritional immunity]
V --> W[Hepcidin blocks ferroportin]
V --> X[Lactoferrin binds iron]
W --> Y[Iron sequestration]
X --> Y
Y --> Z["Salmonella siderophores: enterobactin/salmochelin"]
Z --> AA[Bacterial iron scavenging]
Chronic Carriage:
- In ~2-5% of infected individuals, Salmonella persists in gallbladder after acute infection resolves
- Forms biofilms on gallstones (cholesterol stones provide attachment substrate) → protected from antibiotics and immune clearance
- Biofilm bacteria express different metabolic programs (stationary phase, low oxygen) → phenotypically resistant to antibiotics even without genetic resistance
- Chronic carriers shed bacteria intermittently in feces → public health reservoir (famous case: Typhoid Mary carried S. typhi for decades)
Evolutionary Selection Pressure:
- Blood type O individuals show 30-50% reduced risk of severe Salmonella infection compared to blood types A and B
- Mechanism: ABO blood group antigens expressed on gut epithelium and RBCs; Salmonella adhesins preferentially bind A and B antigens → type O lacks these receptors
- This selective pressure increased frequency of O allele in populations with endemic enteric pathogens (Sub-Saharan Africa, South Asia)
- Illustrates gene-pathogen coevolution and Evolutionary medicine principles—what protects against infection may have trade-offs elsewhere (e.g., O blood type associated with higher bleeding risk, peptic ulcer susceptibility)
Selfish Brain and Nutritional Immunity:
- Iron withholding during infection is a double-edged sword: protects against pathogen but may worsen Anemia of chronic disease
- Chronic Salmonella carriage can lead to persistent low-grade Inflammation and Inflammaging
- Demonstrates tension between Innate immunity (rapid but costly) and tolerating some pathogen burden to preserve metabolic resources
Clinical Risk Factors (Immune and Barrier Dysfunction):
- PPI use: Reduces stomach acid → 3-8x increased risk of Salmonella infection (normal gastric pH <2.0 kills most bacteria; PPI raises pH to 4-6)
- Chronic stress: Elevated cortisol → Glucocorticoid Receptor activation → suppresses NF-kB signaling → reduced cytokine production → impaired bacterial clearance
- HIV/AIDS: CD4+ T cell depletion → loss of IFN-γ-producing cells → macrophages can't activate bactericidal mechanisms → increased non-typhoidal Salmonella (NTS) bacteremia in sub-Saharan Africa
- Microbiome disruption: Recent antibiotic use destroys colonization resistance (commensal bacteria compete for nutrients and niches) → Salmonella blooms in ecological void
- Inflammatory bowel disease: Pre-existing Gut barrier damage and dysregulated immune response → more severe infections
Hygiene Hypothesis and Immune Development:
- Early-life exposure to diverse microbes (including enteric pathogens in moderate doses) may train Innate immunity and Treg cells
- Excessive sanitation in WEIRD populations may reduce immune competence against real pathogens
- However, this does NOT mean Salmonella infection is beneficial—it's a pathogen, not a commensal
- The nuance: balanced immune education requires microbial diversity, not virulent pathogens
Interventions and Clinical Thresholds:
- Prevention: Maintain stomach acid (avoid unnecessary PPIs), optimize Vitamin D (supports antimicrobial peptide production), ensure adequate zinc (supports T cell function)
- Acute treatment: Oral rehydration for gastroenteritis (antibiotics not recommended for uncomplicated cases—prolongs carriage and drives resistance); reserve antibiotics for invasive disease (bacteremia, typhoid)
- Chronic carriage: May require cholecystectomy if gallbladder harbors biofilm; long-term antibiotics often fail
- Biomarker: Fecal Calprotectin elevated (>200 μg/g) during acute Salmonella gastroenteritis; blood culture positive in typhoid fever
Antibiotic Resistance Crisis:
- Multidrug-resistant (MDR) Salmonella increasingly common: resistance to ampicillin, chloramphenicol, trimethoprim-sulfamethoxazole
- Extensively drug-resistant (XDR) strains emerging: resistant to fluoroquinolones and third-generation cephalosporins
- Resistance often carried on plasmids → horizontal gene transfer to other Enterobacteriaceae
- Emphasizes importance of Nutritional immunity, microbiome health, and barrier integrity as first-line defenses rather than relying on antibiotics
- Causes ~93 million cases of gastroenteritis and ~150,000 deaths annually worldwide (WHO data)
- Incubation period: 6-72 hours post-ingestion (typically 12-36 hours)
- Infectious dose: as few as 10-100 organisms for some serotypes (e.g., S. typhi); 10⁵-10⁹ for others (e.g., S. enteritidis)
- Blood group O provides ~40% protection against severe infection (odds ratio 0.6 in meta-analyses)
- Stomach acid is critical first defense: pH <2.0 kills 99.99% of ingested bacteria within 30 minutes
- PPI use increases infection risk 3-8 fold (meta-analysis: OR 3.33, 95% CI 1.84-6.02)
- Siderophore enterobactin has iron affinity Kd ~10⁻⁵² M (among highest known in biology)
- Chronic carriage rate: 2-5% after acute infection; higher in individuals with gallstones (10-25%)
- Common food sources: poultry (40-50% contamination rates), eggs (especially undercooked), reptiles (pet turtles, lizards), contaminated produce (sprouts, melons, tomatoes)
- Tetrathionate respiration during inflammation gives Salmonella 100-1000x growth advantage over obligate anaerobes
- Biofilm formation on gallstones increases antibiotic resistance 10-1000 fold (phenotypic, not genetic)
- Fecal shedding can persist 4-6 weeks after symptom resolution even without chronic carriage
- Blood group O — provides evolutionary protection against severe Salmonella infection via reduced adhesin binding to gut epithelium
- Nutritional immunity — host iron sequestration (hepcidin, lactoferrin, transferrins) limits bacterial growth; Salmonella counters with high-affinity siderophores
- Iron — central battleground in host-pathogen conflict; excessive supplementation may fuel infection
- Siderophores — bacterial enterobactin and salmochelin scavenge iron with femtomolar affinity, overcoming lactoferrin binding
- Ferritin — iron storage protein; host sequesters iron here during infection to starve bacteria
- Transferrins — serum iron-binding proteins; only 20-30% saturated normally, leaving little free iron
- Hepcidin — master iron regulator; upregulated during infection to block ferroportin and trap iron intracellularly
- Gut barrier — Salmonella invades via M cells and enterocytes; barrier dysfunction increases translocation risk
- Stomach acid — first-line defense kills most ingested bacteria; PPI use catastrophically raises infection risk
- PPI — proton pump inhibitors reduce gastric acidity from pH 1.5 to pH 4-6, allowing bacterial survival
- Macrophages — Salmonella survives intracellularly by blocking phagosome-lysosome fusion and manipulating vesicle trafficking
- IL-8 — potent neutrophil chemoattractant; drives inflammatory diarrhea and pathogen clearance attempts
- TNF-α — pro-inflammatory cytokine that increases vascular permeability and disrupts tight junctions, contributing to diarrhea
- IL-6 — acute phase cytokine that triggers fever and hepatic acute phase protein synthesis
- NLRP3 inflammasome — activated by bacterial flagellin and T3SS components, producing IL-1β and pyroptosis
- NF-kB — master transcription factor for inflammatory cytokines; activated by TLR4 recognition of Salmonella LPS
- TLR4 — pattern recognition receptor that binds bacterial LPS lipid A, initiating innate immune cascade
- Evolutionary medicine — Salmonella drove positive selection for blood group O in endemic regions; illustrates pathogen-host coevolution
- Hygiene hypothesis — excessive sanitation may reduce microbial exposure needed for immune education, but does not justify exposure to virulent pathogens
- Chronic stress — glucocorticoid-mediated immunosuppression increases susceptibility and severity of infection
- Microbiome — colonization resistance from healthy microbiota prevents Salmonella bloom; antibiotics destroy this protection
- Lactobacillus fermentum — probiotic with demonstrated antimicrobial activity against Salmonella via bacteriocin production and pH reduction
- Diarrhea — primary symptom; inflammatory mediators (PGE2, IL-8) and toxins increase intestinal secretion and motility
- Antibiotic resistance — MDR and XDR Salmonella strains increasingly common; horizontal gene transfer accelerates spread
- Inflammation — acute inflammatory response is double-edged: helps clear bacteria but also provides tetrathionate for bacterial respiration
- Peyer's patches — organized lymphoid tissue in gut where Salmonella preferentially invades via M cells
- Innate immunity — first-line defenses (acid, antimicrobial peptides, phagocytes, nutritional immunity) critical for containment
- Adaptive immunity — CD4+ T cells produce IFN-γ to activate macrophages; B cells produce opsonizing antibodies for future protection
- LPS — lipopolysaccharide endotoxin in Salmonella outer membrane; TLR4 ligand that triggers cytokine storm
- Tetrathionate — sulfur compound produced during inflammation; Salmonella uses it as electron acceptor for anaerobic respiration advantage
- Enterobacteriaceae — family including Salmonella, E. coli, Klebsiella; often overgrow when commensals depleted
- Lactoferrin — iron-binding glycoprotein in mucus and neutrophil granules; sequesters iron from bacteria (but can be overcome by siderophores)
- Zonulin — tight junction regulator; increased during Salmonella infection, contributing to barrier permeability
- Glucocorticoid Receptor — chronic stress-induced cortisol signaling suppresses NF-κB and impairs pathogen clearance
- Module 1 — Gut barrier, stomach acid, microbial interactions, lactose intolerance context
- Module 7 — Infectious disease, evolutionary pressures, blood group selection, nutritional immunity